 |
Trøseid Marius; Arribas José R; Assoumou Lambert; Holten Aleksander Rygh; Poissy Julien; Terzić Vida; Mazzaferri Fulvia; Baño Jesús Rodríguez; Eustace Joe; Hites Maya; Joannidis Michael; Paiva José-Artur; Reuter Jean; Püntmann Isabel; Patrick-Brown Thale D J H; Westerheim Elin; Nezvalova-Henriksen Katerina; Beniguel Lydie; Dahl Tuva Børresdatter; Bouscambert Maude; Halanova Monika; Péterfi Zoltán; Tsiodras Sotirios; Rezek Michael; Briel Matthias; Ünal Serhat; Schlegel Martin; Ader Florence; Lacombe Karine; Amdal Cecilie Delphin; Kollaborációs szervezet: EU SolidAct study group; Hajdu Edit; et al.:
Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct) : a randomised, double-blind, placebo-controlled phase 3 trial.
CRITICAL CARE, 27 (1).
ISSN 1364-8535
(2023)
Rello Jordi; Krenn Claus-Georg; Locker Gottfried; Pilger Ernst; Madl Christian; Bogár Lajos; Molnár Zsolt; Völgyes Barbara; Krémer Ildikó; Lyons Arthur; Joannidis Michael; Burgmann Heinz; Welte Tobias; Klingler Anton; Hochreiter Romana:
A randomized placebo-controlled phase II study of a Pseudomonas vaccine in ventilated ICU patients.
CRITICAL CARE, 21 (1).
Terjedelem: 13 p-Azonosító: 22.
ISSN 1364-8535
(2017)
![[Fel]](/style/images/multi_up.png)
Vissza
